Variant report
Variant | esv3508199 |
---|---|
Chromosome Location | chr9:110017856-110022181 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:110007992..110013194-chr9:110021107..110025881,5 | MCF-7 | breast: | |
2 | chr9:110014211..110018622-chr9:110040932..110043716,4 | MCF-7 | breast: | |
3 | chr9:110021032..110023010-chr9:110046369..110047881,2 | MCF-7 | breast: | |
4 | chr9:110021549..110024530-chr9:110031690..110034147,2 | MCF-7 | breast: | |
5 | chr9:110017405..110019153-chr9:110019371..110020959,2 | MCF-7 | breast: | |
6 | chr9:110015966..110018595-chr9:110020108..110022273,3 | MCF-7 | breast: | |
7 | chr9:110017405..110019153-chr9:110019371..110020959,2 | MCF-7 | breast: | |
8 | chr9:110015966..110018595-chr9:110020108..110022273,3 | MCF-7 | breast: | |
9 | chr9:110021248..110023658-chr9:110046181..110048340,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RAD23B-3 | chr9:110017675-110017878 | XLOC_007504 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000119318 | chromatin interactions |
MRPS34 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576397001 | chr9:110017861-110017862 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs147502624 | chr9:110017866-110017867 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs10816476 | chr9:110017886-110017887 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs192911642 | chr9:110017912-110017913 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183897964 | chr9:110017924-110017925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548883276 | chr9:110017925-110017926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559155634 | chr9:110017929-110017930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10122970 | chr9:110017948-110017949 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs544563335 | chr9:110017964-110017965 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562982577 | chr9:110017968-110017969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531104873 | chr9:110018011-110018012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549291669 | chr9:110018020-110018021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111949333 | chr9:110018021-110018022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112569642 | chr9:110018029-110018030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528653221 | chr9:110018048-110018049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs150543518 | chr9:110018144-110018145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571611316 | chr9:110018187-110018188 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532682219 | chr9:110018199-110018200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs202217177 | chr9:110018256-110018257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200432070 | chr9:110018283-110018284 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10978773 | chr9:110018287-110018288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374775653 | chr9:110018306-110018307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs13284543 | chr9:110018319-110018320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7870894 | chr9:110018327-110018328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9696210 | chr9:110018329-110018330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs71368006 | chr9:110018331-110018332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550992700 | chr9:110018345-110018346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs28667796 | chr9:110018354-110018355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550519209 | chr9:110018844-110018845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113506220 | chr9:110019215-110019216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs55959626 | chr9:110020132-110020133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547864827 | chr9:110020154-110020155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547150340 | chr9:110020207-110020208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572319146 | chr9:110020247-110020248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561390994 | chr9:110020274-110020275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565457983 | chr9:110020277-110020278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576991411 | chr9:110020305-110020306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545908104 | chr9:110020343-110020344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568700268 | chr9:110020364-110020365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs4250429 | chr9:110020417-110020418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs28545171 | chr9:110020438-110020439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs28433544 | chr9:110020525-110020526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs28687405 | chr9:110020562-110020563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs28646176 | chr9:110020615-110020616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs28681278 | chr9:110020638-110020639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569303142 | chr9:110020647-110020648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537327991 | chr9:110020650-110020651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555667267 | chr9:110020654-110020655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs28472873 | chr9:110020668-110020669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs28744681 | chr9:110020676-110020677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Fukuyama congenital muscular dystrophy | 21572526 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 21147756 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:110007000-110022600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr9:110012400-110022600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr9:110014800-110021400 | Weak transcription | Adipose Nuclei | Adipose |
4 | chr9:110014800-110022800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr9:110015400-110022600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr9:110017000-110018400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr9:110017200-110022600 | Weak transcription | HSMMtube | muscle |
8 | chr9:110017600-110018000 | Enhancers | Pancreas | Pancrea |
9 | chr9:110017600-110018200 | Enhancers | HepG2 | liver |
10 | chr9:110018200-110018400 | Enhancers | Primary T cells from cord blood | blood |
11 | chr9:110018200-110018400 | Enhancers | Primary hematopoietic stem cells | blood |
12 | chr9:110018200-110022400 | Weak transcription | HepG2 | liver |
13 | chr9:110020800-110022600 | Weak transcription | NHDF-Ad | bronchial |
14 | chr9:110021000-110023800 | Enhancers | Liver | Liver |
15 | chr9:110021400-110021600 | Enhancers | Adipose Nuclei | Adipose |
16 | chr9:110021400-110022600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
17 | chr9:110021400-110024000 | Enhancers | Primary B cells from peripheral blood | blood |
18 | chr9:110021600-110022600 | Weak transcription | Adipose Nuclei | Adipose |
19 | chr9:110021800-110022600 | Enhancers | Primary B cells from cord blood | blood |
20 | chr9:110022000-110022200 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |